Ligand Pharmaceuticals (LGND) Tax Rate Growth (1y) (2011 - 2026)
Ligand Pharmaceuticals (LGND) Tax Rate Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 5.95 Bn | 5.17 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,959.00 |
| Dec 31, 2025 | 43.00 |
| Sep 30, 2025 | 3,005.00 |
| Jun 30, 2025 | 3,620.00 |
| Mar 31, 2025 | -867.00 |
| Dec 31, 2024 | 2,708.00 |
| Sep 30, 2024 | -2,855.00 |
| Jun 30, 2024 | -717.00 |
| Mar 31, 2024 | 260.00 |
| Dec 31, 2023 | -16,659.00 |
| Sep 30, 2023 | -652.00 |
| Jun 30, 2023 | 7,325.00 |
| Mar 31, 2023 | 6,286.00 |
| Dec 31, 2022 | 13,738.00 |
| Sep 30, 2022 | 1,186.00 |
| Jun 30, 2022 | -5,320.00 |
| Mar 31, 2022 | 17,273.00 |
| Dec 31, 2021 | 3,856.00 |
| Sep 30, 2021 | -3,223.00 |
| Jun 30, 2021 | -1,372.00 |